p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage

Oncogene

Volumn 13, Issue 7, 1996, Pages 1387-1393

  Knippschild, Uwe ^a   Milne, Diane ^a   Campbell, Linda ^a   Meek, David ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

DNA damage; p53; Protein kinase

Indexed keywords

CAMPTOTHECIN; ETOPOSIDE; PROTEIN KINASE; PROTEIN P53; SERINE; VALINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL LYSATE; DNA DAMAGE; ENZYME ACTIVITY; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; PRIORITY JOURNAL; TEMPERATURE; TUMOR SUPPRESSOR GENE;

ANIMALS; CARRIER PROTEINS; CELL LINE; DNA DAMAGE; GLUTATHIONE; HELA CELLS; HUMANS; MICE; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN KINASES; RECOMBINANT FUSION PROTEINS; SUBSTRATE SPECIFICITY; TEMPERATURE; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 0029853021     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Barak Y, Juven T, Haffner R and Oren M. (1993). EMBO J., 12, 461-468.
2. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature, 362, 849-852.
3. DeLeo AB, Shiku H, Takahashi T, John M and Old LJ. (1977). J. Exp. Med., 146, 720-734.
4. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M and Davis RJ. (1994). Cell, 76, 1025-1037.
5. Dhillon N and Hoekstra MF. (1994). EMBO J., 13, 2777-2788.
6. Donehower LA and Bradley A. (1993). Biochim. Biophys. Acta., 1155, 181-205.
7. Eliyahu D, Goldfinger N, Pinhasi-Kimhi O, Shaulsky G, Skurnik Y, Arai N, Rotter V and Oren M. (1988). Oncogene, 3, 313-321.
8. Gannon JV and Lane DP. (1991). Nature, 349, 802-806.
9. Gottlieb TM and Jackson SP. (1993). Cell, 72, 131-142.
10. Hoekstra MF, Liskay RM, Ou AC, DeMaggio AJ, Burbee DG and Heffron F. (1991). Science, 253, 1031-1034.
11. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
12. Juven T, Barak Y, Zauberman A, George DL and Oren M. (1993). Oncogene, 8, 3411-3416.
13. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
14. Knippschild U, Kolzau T and Deppert W. (1995). Oncogene, 11, 683-690.
15. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
16. Lane DP. (1992). Nature, 358, 15-16.
17. Lees-Miller SP, Chen Y-R and Anderson CW. (1990). Mol. Cell. Biol., 10, 6472-6481.
18. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD. (1992). Cell, 70, 923-935.
19. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993). Nature, 362, 847-849.
20. Lu X and Lane DP. (1993). Cell, 75, 765-778.
21. Luo K, Hurley TR and Sefton BM. (1991). Methods Enzymol., 201, 149-152.
22. Maltzman W and Czyzyk L. (1984). Mol. Cell. Biol., 4, 1689-1694.
23. Mayr GA, Reed M, Wang P, Wang Y, Schwedes JF and Tegtmeyer P. (1995). Cancer Res., 55, 2410-2417.
24. Meek DW. (1994). Seminars in Cancer Biology, 5, 203-210.
25. Meek DW and Eckhart W. (1988). Mol. Cell. Biol., 8, 461-465.
26. Michalovitz D, Halevy O and Oren M. (1990). Cell, 62, 671-681.
27. Milne DM, Campbell L, Campbell DG and Meek DW. (1995). J. Biol. Chem., 270, 5511-5518.
28. Milne DM, Palmer RH, Campbell DG and Meek DW. (1992). Oncogene, 7, 1361-1369.
29. Nelson WG and Kastan MB. (1994). Mol. Cell. Biol., 14, 1815-1823.
30. Otto A and Deppert W. (1993). Oncogene, 8, 2591-2603.
31. Samad A, Anderson CW and Carroll RB. (1986). Proc. Natl. Acad. Sci. USA, 83, 897-901.
32. Soussi T, Caron de Fromentel C and May P. (1990). Oncogene, 5, 945-952.
33. Wade-Evans A and Jenkins JR. (1985). EMBO J., 4, 699-706.
34. Wang Y and Eckhart W. (1992). Proc. Natl. Acad. Sci. USA, 89, 4231-4235.
35. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM. (1992). Cell, 70, 937-948.